Advertisement

Genetic Evaluation in Developmental Disabilities

  • Helga V. Toriello
Chapter

Abstract

Developmental disabilities are a relatively common reason for referral to a pediatric subspecialist. Although there are numerous reasons for the child being affected with a developmental disability, genetic causes are not an uncommon cause. A genetics evaluation can often identify this cause, and the family counseled appropriately regarding cause, prognosis, and recurrence risks. This chapter describes the various steps in the genetics evaluation process.

Keywords

Autism Spectrum Disorder Autism Spectrum Disorder Down Syndrome Club Foot Rett Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Hall BD, Toriello HV. The pediatric diagnostic examination. New York, NY: McGraw-Hill; 2008.Google Scholar
  2. 2.
    Battaglia A, Bianchini E, Carey JC. Diagnostic yield of the comprehensive assessment of developmental delay/mental retardation in an Institute of child Neuropsychiatry. Am J Med Genet. 1999;82:60–66.PubMedCrossRefGoogle Scholar
  3. 3.
    Bradinova I, Shopova S, Simeonov E. Mental retardation in childhood: clinical and diagnostic profile in 100 children. Genet Couns. 2005;16:239–48.PubMedGoogle Scholar
  4. 4.
    Rauch A, Hoyer J, Guth S, Zweier C, Kraus C, Becker C, Zenker M, Huffmeier U, Thiel C, Ruschendorf F, Nurnberg P, Reis A, Trautmann U. Diagnostic yield of various genetic approaches in patients with unexplained developmental delay or mental retardation. Am J Med Genet. 2006;140A:2063–74.CrossRefGoogle Scholar
  5. 5.
    Engbers H, Berger R, van Hasselt P, de Koning T, de Sain-van der Velden MGM, Kroes HY, Visser G. Yield of additional metabolic studies in neurodevelopmental disorders. Ann Neurol. 2008;64:212–17.PubMedCrossRefGoogle Scholar
  6. 6.
    Van Karnebeek CDM, Jansweijer MCE, Leenders AGE, Offringa M, Hennekam RCM. Diagnostic investigations in individuals with mental retardation: a systematic literature review of their usefulness. Eur J Hum Genet. 2005;13:6–25.PubMedCrossRefGoogle Scholar
  7. 7.
    Curry CJ, Stevenson RE, Aughton D, Byrne J, Carey JC, Cassidy S, Cunniff C, Graham JM, Jones MC, Kaback MM, Moeschler J, Schaefer GB, Schwartz S, Tarleton J, Opitz J. Evaluation of mental retardation: recommendations of a consensus conference. Am J Med Genet. 1997;72:468–77.PubMedCrossRefGoogle Scholar
  8. 8.
    Shevell M, Ashwal S, Donley D, Flint J, Gingold M, Hirtz D, Majnemer A, Noetzel M, Sheth RD. Practice parameter: evaluation of the child with global developmental delay. Neurol. 2003;60:367–80.CrossRefGoogle Scholar
  9. 9.
    Moeschler JB, Shevell M. Committee on genetics. clinical genetic evaluation of the child with mental retardation or developmental delays. Pediatrics. 2006;117:2304–16.PubMedCrossRefGoogle Scholar
  10. 10.
    Paciorkowski AR, Fang M. Chromosomal microarray interpretation: what is a child neurologist to do? Pediatr Neurol. 2009;41:391–8.PubMedCrossRefGoogle Scholar
  11. 11.
    Tyson C, Harvard C, Locker R, Friedman JM, Langlois S, Lewis ME, et al. Submicroscopic deletions and duplications in individuals with intellectual disability detected by array-CGH. Am J Med Genet. 2005;139A:173–85.CrossRefGoogle Scholar
  12. 12.
    Wincent J, Anderlid BM, Lagerberg M, Nordenskjold M, Schoumans J. High-resolution molecular karyotyping in patients with developmental delay and/or multiple congenital anomalies in a clinical setting. Clin Genet. 2010;doi:10/1111/j.1399–004.2010.01442.x.Google Scholar
  13. 13.
    Miller DT, Adam MP, Aradhya S, Biesecker LG, Brothman AR, Carter NP, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet. 2010;86:749–64.PubMedCrossRefGoogle Scholar
  14. 14.
    Sharp AJ, Mefford HC, Li K, Baker C, Skinner C, Stevenson RE, et al. A recurrent 15q13.3 microdeletion syndrome associated with mental retardation and seizures. Nat Genet. 2008;40:322–8.PubMedCrossRefGoogle Scholar
  15. 15.
    Shinawi M, Liu P, Kang SH, Shen I, Belmont JW, Scott DA, et al. Recurrent reciprocal 16p11.2 rearrangements associated with global developmental delay, behavioural problems, dysmorphism, epilepsy, and abnormal head size. J Med Genet. 2010;47:332–41.PubMedCrossRefGoogle Scholar
  16. 16.
    Walters RG, Jacquemont S, Valsesia A, deSmith AJ, Andersson D, Falchi M, et al. A new highly penetrant form of obesity due to deletions on chromosome 16p11.2. Nature. 2010;463:671–5.PubMedCrossRefGoogle Scholar
  17. 17.
    Slavotinek AM. Novel microdeletion syndromes detected by chromosome microarrays. Hum Genet. 2008;124:1–17.PubMedCrossRefGoogle Scholar
  18. 18.
    Tan TY, Aftimos S, Worgan L, Susman R, Wilson M, Ghedia S, et al. Phenotypic expansion and further characterisation of the 17q21.31 microdeletion syndrome. J Med Genet. 2009;46:480–9.PubMedCrossRefGoogle Scholar
  19. 19.
    Xiang B, Li A, Valentin D, Nowak NJ, Zhao H, Li P. Analytical and clinical validity of whole-genome oligonucleotide array comparative genomic hybridization for pediatric patients with mental retardation and developmental delay. Am J Med Genet. 2008;146A:1942–54.PubMedCrossRefGoogle Scholar
  20. 20.
    Shearer BM, Thorland EC, Gonzales PR, Ketterling RP. Evaluation of a commercially available focused a CGH platform for the detection of constitutional chromosome anomalies. Am J Med Genet. 2007;143A:2357–70.PubMedCrossRefGoogle Scholar
  21. 21.
    Lu X, Shaw CA, Patel A, Li J, Cooper ML, Wells WR, et al. Clinical implementation of chromosomal microarray analysis: summary of 2513 postnatal cases. PLoS One. 2007;28:e327.CrossRefGoogle Scholar
  22. 22.
    Toriello HV. Intellectual disability and genetic influences. Int J Disabil Hum Dev. 2008;7:349–54.CrossRefGoogle Scholar
  23. 23.
    Engbers JM, Nievelstein RAJ, Gooskens RHJM, Kroes HY, van Empelen R, Braams O, et al. The clinical utility of MRI in patients with neurodevelopmental disorders of unknown origin. Eur J Neurol. 2010;17:815–22.PubMedCrossRefGoogle Scholar
  24. 24.
    Bashiardes S, Kousoulidou L, van Bokhoven H, Ropers HH, Chelly J, Moraine C, et al. A new chromosome X exon-specific microarray platform for screening of patients with X-linked disorders. J Mol Diagn. 2009;11:562–8.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2011

Authors and Affiliations

  1. 1.Department of Pediatrics and Human DevelopmentMichigan State University College of Human MedicineEast LansingUSA
  2. 2.Spectrum HealthGrand RapidsUSA

Personalised recommendations